31 related articles for article (PubMed ID: 9402966)
1. Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: A reappraisal of haplotype data.
Colombo R
Am J Hum Genet; 2000 Feb; 66(2):692-7. PubMed ID: 10677327
[TBL] [Abstract][Full Text] [Related]
2. Implications for health and disease in the genetic signature of the Ashkenazi Jewish population.
Guha S; Rosenfeld JA; Malhotra AK; Lee AT; Gregersen PK; Kane JM; Pe'er I; Darvasi A; Lencz T
Genome Biol; 2012 Jan; 13(1):R2. PubMed ID: 22277159
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial and Y chromosome haplotype motifs as diagnostic markers of Jewish ancestry: a reconsideration.
Tofanelli S; Taglioli L; Bertoncini S; Francalacci P; Klyosov A; Pagani L
Front Genet; 2014; 5():384. PubMed ID: 25431579
[TBL] [Abstract][Full Text] [Related]
4. Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.
Risch N; Tang H; Katzenstein H; Ekstein J
Am J Hum Genet; 2003 Apr; 72(4):812-22. PubMed ID: 12612865
[TBL] [Abstract][Full Text] [Related]
5. Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
Rivas MA; Avila BE; Koskela J; Huang H; Stevens C; Pirinen M; Haritunians T; Neale BM; Kurki M; Ganna A; Graham D; Glaser B; Peter I; Atzmon G; Barzilai N; Levine AP; Schiff E; Pontikos N; Weisburd B; Lek M; Karczewski KJ; Bloom J; Minikel EV; Petersen BS; Beaugerie L; Seksik P; Cosnes J; Schreiber S; Bokemeyer B; Bethge J; ; ; ; Heap G; Ahmad T; Plagnol V; Segal AW; Targan S; Turner D; Saavalainen P; Farkkila M; Kontula K; Palotie A; Brant SR; Duerr RH; Silverberg MS; Rioux JD; Weersma RK; Franke A; Jostins L; Anderson CA; Barrett JC; MacArthur DG; Jalas C; Sokol H; Xavier RJ; Pulver A; Cho JH; McGovern DPB; Daly MJ
PLoS Genet; 2019 May; 15(5):e1008190. PubMed ID: 31145742
[TBL] [Abstract][Full Text] [Related]
6. Computing a cure for fragile-X syndrome.
Mohamad T; Lepage JF
Brain Commun; 2024; 6(2):fcae066. PubMed ID: 38482376
[No Abstract] [Full Text] [Related]
7. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
[TBL] [Abstract][Full Text] [Related]
8. [Molecular and genetic features of fragile X syndrome].
Jara L; Avendaño I; Aspillaga M; Blanco R
Rev Med Chil; 1996 Jul; 124(7):865-72. PubMed ID: 9138377
[TBL] [Abstract][Full Text] [Related]
9. Explanations for the discrepancy between variant frequency and homozygous disease occurrence: Lessons from Ashkenazi Jewish data.
Zlotogora J; Harel T; Meiner V
Eur J Med Genet; 2023 Jun; 66(6):104765. PubMed ID: 37028505
[TBL] [Abstract][Full Text] [Related]
10. No founder effect detected in Jewish Ashkenazi patients with fragile-X syndrome.
Pesso R; Barkai G; Ravia Y; Gak E; Frydman M; Goldman B; Friedman E
Hum Genet; 1997 Dec; 101(2):186-9. PubMed ID: 9402966
[TBL] [Abstract][Full Text] [Related]
11. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype.
Falik-Zaccai TC; Shachak E; Yalon M; Lis Z; Borochowitz Z; Macpherson JN; Nelson DL; Eichler EE
Am J Hum Genet; 1997 Jan; 60(1):103-12. PubMed ID: 8981953
[TBL] [Abstract][Full Text] [Related]
12. Fragile X founder effects in Argentina.
Bonaventure G; Torrado M; Barreiro C; Chertkoff L
Am J Med Genet; 1998 Sep; 79(3):200-4. PubMed ID: 9788562
[TBL] [Abstract][Full Text] [Related]
13. Haplotype and AGG interspersion analysis of FMR1 alleles in a Croatian population: no founder effect detected in patients with fragile X syndrome.
Dokić H; Barisić I; Culić V; Lozić B; Hećimović S
Hum Biol; 2008 Oct; 80(5):581-7. PubMed ID: 19341325
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analysis at the FRAXA locus in an Indian population.
Chakraborty SS; Mondal BC; Das S; Das K; Dasgupta UB
Am J Med Genet A; 2008 Aug; 146A(15):1980-5. PubMed ID: 18627041
[TBL] [Abstract][Full Text] [Related]
15. Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity?
Zhong N; Ye L; Dobkin C; Brown WT
Am J Med Genet; 1994 Jul; 51(4):405-11. PubMed ID: 7943008
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
